Wei Gu

29PUBLICATIONS

154CO-AUTHORS

Molecular targetsTumour immunologyPsychopharmacologyPredictive and prognostic markersCancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (29)

Sort by Publication Date:

|Jul 01, 2026

Correction: SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.

|May 27, 2026

MPND Loss Epigenetically Activates TGF-β/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non-small Cell Lung Cancer.

|Apr 01, 2026

The Moving Target: Cis-Mutation-Driven Resistance to p53-Y220C Reactivator.

Yanqing Liu, Wei Gu

|Sep 19, 2025

Activation of T Cell-Intrinsic p53 by Acetylation Elicits Antitumor Immunity to Boost Cancer Immunotherapy.

Xiaojun Yan, Wenbin Xu, Han Yao

|Jun 25, 2025

The PURB-HOTAIR complex regulates p53-dependent promoter-specific transcriptional activation.

Zhangchuan Xia, Ning Kon, Zhenyi Su

|Apr 09, 2025

p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases.

Yanqing Liu, Brent R Stockwell, Xuejun Jiang

Pageof 5

Frequent Collaborators

Zhiguo Zhang

Xuejun Jiang

Brent R Stockwell

Zhiming Li

Bo Chu

Xin Yang

Zhen Wu

Xiaojun Yan

Xingwu Wang

Donglai Wang

Frequent Collaborators

Zhiguo Zhang

Xuejun Jiang

Brent R Stockwell

Zhiming Li